Natural killer T cells acquire their unique phenotype and characteristics during development in the thymus. Evidence suggests that the transcription factor PLZF has a unique function in the ...

NKT has entered into an agreement to divest NKT Photonics, to Photonics Management Europe S.R.L, a 100% owned subsidiary of Hamamatsu Photonics K.K. which is a Japanese company engaged in developing ...

The Board of Directors of NKT A/S has decided to exercise the authority to buy back shares granted by the Annual General Meeting on 25 March 2021. The authorisation is valid in the period until 31 ...

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with ...

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with ...

After five years as Chief Financial Officer (CFO) of NKT, Line Andrea Fandrup has decided to leave the company no later than the end of April 2026. She will leave NKT after serving as CFO during a ...

The gastrointestinal tract allows the residence of an almost enumerable number of bacteria. To maintain homeostasis, the mucosal immune system must remain tolerant to the commensal microbiota and ...

Danish subsea cable and services firm NKT has boosted the offshore installation capabilities of its cable laying vessel (CLV) NKT Victoria by conducting several technical upgrades. According to NKT, ...

Luna Innovations, the Nasdaq-listed US company, has sharpened its focus on fiber-optic technologies, with the acquisition of the "LIOS" sensing business from Denmark's NKT Photonics. Bought for €20 ...

HOUSTON--(BUSINESS WIRE)--Kuur Therapeutics today announced the launch of its new business in partnership with Baylor College of Medicine and Baylor’s Center for Cell and Gene Therapy. Houston-based ...

As NKT continues to execute on its strategy, ReNew BOOST, financial ambitions for 2028 are updated to reflect the effects of the ongoing investments and the underlying profitability of the ...

Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and immunoediting compared with single-pathway CAR-T constructs. Complete tumor ...